ATE490780T1 - Menschliches wachstumshormon zur behandlung von anorexia nervosa - Google Patents

Menschliches wachstumshormon zur behandlung von anorexia nervosa

Info

Publication number
ATE490780T1
ATE490780T1 AT97929492T AT97929492T ATE490780T1 AT E490780 T1 ATE490780 T1 AT E490780T1 AT 97929492 T AT97929492 T AT 97929492T AT 97929492 T AT97929492 T AT 97929492T AT E490780 T1 ATE490780 T1 AT E490780T1
Authority
AT
Austria
Prior art keywords
growth hormone
anorexia nervosa
treatment
nutrition
human growth
Prior art date
Application number
AT97929492T
Other languages
English (en)
Inventor
Kiyoshi Hashizume
Original Assignee
Japan Chem Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Chem Res filed Critical Japan Chem Res
Application granted granted Critical
Publication of ATE490780T1 publication Critical patent/ATE490780T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Confectionery (AREA)
  • Steroid Compounds (AREA)
AT97929492T 1996-07-10 1997-07-02 Menschliches wachstumshormon zur behandlung von anorexia nervosa ATE490780T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20124896 1996-07-10
PCT/JP1997/002283 WO1998001152A1 (fr) 1996-07-10 1997-07-02 Medicaments pour les troubles alimentaires

Publications (1)

Publication Number Publication Date
ATE490780T1 true ATE490780T1 (de) 2010-12-15

Family

ID=16437800

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97929492T ATE490780T1 (de) 1996-07-10 1997-07-02 Menschliches wachstumshormon zur behandlung von anorexia nervosa

Country Status (7)

Country Link
US (1) US6225283B1 (de)
EP (1) EP0916345B1 (de)
JP (1) JP4171070B2 (de)
AT (1) ATE490780T1 (de)
AU (1) AU3357997A (de)
DE (1) DE69740072D1 (de)
WO (1) WO1998001152A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1663277A2 (de) * 2003-08-20 2006-06-07 Neuren Pharmaceuticals Limited Somatogene therapie mit einer 20kda plazentavariante des wachstumshormons

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024919A1 (en) * 1994-03-15 1995-09-21 K.U. Leuven Research & Development New use of growth hormone
AU693478B2 (en) * 1994-11-10 1998-07-02 Metabolic Pharmaceuticals Limited Treatment of obesity

Also Published As

Publication number Publication date
US6225283B1 (en) 2001-05-01
JP4171070B2 (ja) 2008-10-22
EP0916345A4 (de) 2008-08-06
WO1998001152A1 (fr) 1998-01-15
EP0916345B1 (de) 2010-12-08
DE69740072D1 (de) 2011-01-20
EP0916345A1 (de) 1999-05-19
AU3357997A (en) 1998-02-02

Similar Documents

Publication Publication Date Title
DE69739792D1 (de) Verfahren zur Behandlung von Augenerkrankungen
EP1039802A4 (de) Transdermale therapeutische vorrichtung mit capsaicin und seine analoga
EP1201241B8 (de) Zusammensetzungen enthaltend Capsaicin oder Capsaicin Analoge und ein Anästhetikum
DE60138547D1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE69736745D1 (de) Verfahren zur behandlung von prostaterkrankungen unter verwendung von vitamin-d-formulierungen mit verzögerter und/oder verlängerter wirkstofffreigabe
ATE277638T1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
ATE170769T1 (de) Vorrichtung zur verabreichung von medikamenten durch elektrotransport
ATE141505T1 (de) Verwendung von 3-guanidinopropionsäure zur herstellung eines medikaments zur behandlung und prävention von fettsucht
AU1865100A (en) Hyaluronate lyase used for promoting penetration in topical agents
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
MX9701187A (es) Nuevas lactamas naftofusionadas n-substituidas.
DE60119976D1 (en) Thixotropes nasenspray
ATE454451T1 (de) Methode zur behandlung von muskelkrankheiten
BR9808114A (pt) Formulação de ração para cavalos utilizável para tratar epm, processos para tratar pm em um cavalo que necessita deste tratamento, para prevenir infecção com s. neutrona em cavalos, e, para exterminar s. neurona em cavalos
DE69326122D1 (de) Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen
ATE490780T1 (de) Menschliches wachstumshormon zur behandlung von anorexia nervosa
ATE291918T1 (de) Kombinationstherapie zur behandlung von tumoren
DE60028559D1 (de) Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone
WO2000078328A3 (de) VERWENDUNG VON WACHSTUMSHORMON (hGH) ZUR THERAPIE SEXUELLER FUNKTIONSSTÖRUNGEN
ATE279939T1 (de) Phytase zur vorbeugung oder behandlung von mastitis
DE60024969D1 (de) 2-methyl-3-butenyl-1-pyrophosphorsäuresalze und mittel zur behandlung von lymphozyten
CA2260148A1 (en) Remedies for eating disorders
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties